Your browser doesn't support javascript.
loading
Exploratory analysis of rare and novel variants in Mexican patients diagnosed with schizophrenia and dementia
Martínez-Magaña, José J.; Genís-Mendoza, Alma D.; González-Covarrubias, Vanessa; Jiménez-Guenchi, Janet; Galindo-Chávez, Aidé G.; Roche-Bergua, Andrés; Castañeda-González, Carlos; Lanzagorta, Nuria; Soberón, Xavier; Nicolini, Humberto.
  • Martínez-Magaña, José J.; Instituto Nacional de Medicina Genómica. Genomics Laboratory of Psychiatric and Neurodegenerative Diseases. Mexico City. MX
  • Genís-Mendoza, Alma D.; Instituto Nacional de Medicina Genómica. Genomics Laboratory of Psychiatric and Neurodegenerative Diseases. Mexico City. MX
  • González-Covarrubias, Vanessa; Instituto Nacional de Medicina Genómica. Pharmacogenomics Laboratory. Mexico City. MX
  • Jiménez-Guenchi, Janet; SSA. Hospital Psiquiátrico Fray Bernardino Alvarez. Mexico City. MX
  • Galindo-Chávez, Aidé G.; SSA. Hospital Psiquiátrico Fray Bernardino Alvarez. Mexico City. MX
  • Roche-Bergua, Andrés; SSA. Hospital Psiquiátrico Fray Bernardino Alvarez. Mexico City. MX
  • Castañeda-González, Carlos; SSA. Hospital Psiquiátrico Fray Bernardino Alvarez. Mexico City. MX
  • Lanzagorta, Nuria; Grupo de Estudios Médicos y Familiares. Mexico City. MX
  • Soberón, Xavier; Instituto Nacional de Medicina Genómica. Pharmacogenomics Laboratory. Mexico City. MX
  • Nicolini, Humberto; Instituto Nacional de Medicina Genómica. Genomics Laboratory of Psychiatric and Neurodegenerative Diseases. Mexico City. MX
Rev. invest. clín ; 71(4): 246-254, Jul.-Aug. 2019. tab
Article Dans Anglais | LILACS | ID: biblio-1289693
ABSTRACT
Abstract Background Schizophrenia (SCZ) and dementia, often related, are two of the most common neuropsychiatric diseases; epidemiological studies have shown that SCZ patients present a 2-fold increased risk for dementia compared to non-schizophrenic individuals. We explored the presence of rare and novel damaging gene variants in patients diagnosed with late-onset dementia of Alzheimer’s type (DAT) or SCZ. Methods We included 7 DAT and 12 SCZ patients and performed high-depth targeted sequencing of 184 genes. Results We found novel and rare damaging variants in 18 genes in these Mexican patients. Carriers of these variants showed extreme phenotypes, including, treatment-resistant SCZ or cognitive decline. Furthermore, we found a variation on ABCC1 as a possible link between psychosis and cognitive impairment. Discussion As an exploratory analysis, we report some interesting variations that should be corroborated in larger sample size studies.
Sujets)


Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Schizophrénie / Démence / Maladie d'Alzheimer / Dysfonctionnement cognitif Type d'étude: Etude diagnostique Limites du sujet: Humains Pays comme sujet: Mexico langue: Anglais Texte intégral: Rev. invest. clín Thème du journal: Médicament Année: 2019 Type: Article Pays d'affiliation: Mexique Institution/Pays d'affiliation: Grupo de Estudios Médicos y Familiares/MX / Instituto Nacional de Medicina Genómica/MX / SSA/MX

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Schizophrénie / Démence / Maladie d'Alzheimer / Dysfonctionnement cognitif Type d'étude: Etude diagnostique Limites du sujet: Humains Pays comme sujet: Mexico langue: Anglais Texte intégral: Rev. invest. clín Thème du journal: Médicament Année: 2019 Type: Article Pays d'affiliation: Mexique Institution/Pays d'affiliation: Grupo de Estudios Médicos y Familiares/MX / Instituto Nacional de Medicina Genómica/MX / SSA/MX